Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV)

Following guidance from the Joint Committee on Vaccination and Immunisation, NHS England (NHSE) and the UK Health Security Agency (UKHSA) has today written to systems to set out next steps for delivery of two new respiratory syncytial virus (RSV) vaccination programmes from 1 September 2024. The programmes are for
1) older adults
2) maternal vaccination for infant protection.

The bipartite letter can be viewed on GOV.UK:

Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV) – letter from NHSE and UKHSA

We are organising two webinars for health professionals which will provide an overview of the new programmes.

Speakers from UKHSA and NHSE will outline the key information on the new programmes to support partners involved in the commissioning and delivering the programme. There will be an opportunity for questions and the webinars will be recorded for colleagues unable to attend.

Maternal RSV programme for infant protection: introduction of a new immunisation programme. A webinar for health professionals
9 July 2024 (2.30 – 3.45pm)
via Microsoft Teams Live (joining link to be shared with registered attendees)Registration link for stakeholders

Older adult RSV programme: introduction of a new immunisation programme. A webinar for health professionals
12 July 2024 (2.30 – 3.45pm)
Via Microsoft Teams Live (joining link to be shared with registered attendees)

Registration link for stakeholders

Further details

For any questions about the webinars, please email externalaffairs@ukhsa.gov.uk

For any operational queries, please contact your NHS England Regional Public Health Commissioning Team at england.londonimms@nhs.net

For clinical queries or queries about supporting programme resources, please email immunisation@ukhsa.gov.uk